Clinical Trials Browser

Phase 1/2 × Glioblastoma × ACT001 × Clear all

NCT05053880 2021-11-19

A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Phase 1/2 Unknown

Glioblastoma, Neoplasms